LANLEN VENABLE: Open Payments
NPI 1306300520 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 58 payments from 14 companies in 2025. Trend: 2023 $1,161 · 2024 $1,092 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $280 |
| Lilly USA, LLC | 7 | $120 |
| ABBVIE INC. | 6 | $112 |
| AstraZeneca Pharmaceuticals LP | 5 | $105 |
| PFIZER INC. | 5 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Astellas Pharma US Inc | 4 | $73 |
| Gilead Sciences, Inc. | 3 | $64 |
| Amgen Inc. | 3 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
Products named: Wegovy, MOUNJARO, JARDIANCE, Veozah, UBRELVY, PREVNAR 20, Ozempic, QULIPTA.
Industry payments across NC — which companies pay providers there.
